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ABSTRACT
DISSOLUTION KINETICS OF MODEL API IN MOLTEN POLYMER
EXCIPIENTS DURING BATCH PROCESSING
by
Shen Ji
In the pharmaceutical industrial application field, hot-melt extrusion (HME) has been
recently introduced to develop new solid dosage forms and products. By dissolving the
poorly–soluble active pharmaceutical ingredients (API) into water-soluble polymers, the
bioavailability of the Class II (with low solubility and high permeability in water) API in
Biopharmaceutical Classification System (BCS) could be significantly improved in the
body. For readily water-soluble API, HME provides a new approach to produce a
controlled release drug system. Hence, pharmaceutical HME is a promising processing
method in the pharmaceutical industry.
However, HME has not been widely applied into the pharmaceutical industry.
The thermal degradation of the polymer (and/or other excipients) and API are major
concerns in the pharmaceutical HME process: researchers aim to dissolve the total loading
of the API into the excipient within the short residence time with minimal API degradation.
Therefore, the kinetics of the dissolving process should be known. In this work, the
expression of dissolution process and the impact of shear rate, API concentration and API
species in dissolution kinetics are determined. The viscosities of the mixture at different
shear rates are also measured. A model API shall be dissolved into a polymeric excipient
by conducting melt-mixing experiments using the Brabender Batch Mixer.
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CHAPTER 1

INTRODUCTION

1.1

Objective

Hot-melt extrusion, as an evolving, continuous and solvent-less polymer processing
method, has been recently adopted by the pharmaceutical industry to prepare solid oral
dosage formulations with increased bioavailability for the poorly-water soluble drugs and
controlled release characteristics for the water-soluble drugs (Maniruzzaman, Boateng et
al. 2012). In the case of poorly water-soluble drugs, bioavailability enhancement is
achieved through amorphization of the crystalline drug, such like BCS class II active
pharmaceutical ingredients (APIs). Utilizing HME can improve the bioavailability of the
poorly water-soluble APIs by dissolving them in to water-soluble polymers. Specific
intermolecular bonds with, and steric hindrance effects by the polymer chain prevent the
drug from re-crystallizing. Although the extrusion process during the production of solid
solutions typically takes place below the melting point of the drug, the potential of thermal
degradation of the API still exist and may in fact be a major concern preventing the
universal applicability of the HME technique as a pharmaceutical manufacturing method.
To completely dissolve the API in the formulation while minimizing its potential thermal
degradation, the dissolution kinetics of the API into the excipient must be known. In the
dissolution process, shear rate dependent viscosity is an important material variable: shear
rate can be estimated with a given screw speed and the dimensions of the instruments;
viscosity shall be estimated using the RMS rheometer. Additionally the species, which is
the chemical structure of the API particle also affects the dissolving rate. In this work, we
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determine the dissolution kinetics of a model API into a polymeric excipient by conducting
melt-mixing experiments with a Brabender Batch Mixer.

1.2 Background Information
1.2.1 Hot-melt Extrusion
Hot-melt extrusion has been used in the plastic, rubber, and food manufacturing industry
to produce items such as pipes, sheets, and bags. And it has emerged as a novel processing
technology in developing oral dosage molecular dispersions (solid solutions) of poorly
water-soluble APIs into various hydrophilic polymer matrices. The Hot-melt extrusion
technology has proven to be a robust method of producing numerous drug delivery systems,
and therefore, it has been found to be useful in the pharmaceutical industry as well
(Andrews, 2010; Crowley, 2007). HME involves the compaction and conversion of blends
from a powder or a granular mix into a product of uniform shape (Breitenbach, 2002).
During this process, polymer are melted and formed into products having different shapes
and sizes such as tablets, capsules, films, and implants for drug delivery. The extrusion
process can be broken down to the following general process sections (Chokshi et al. 2004):
(1)

Feeding of the extruder by a hopper;

(2)

Mixing, grinding, reducing the particle size, and kneading;

(3)

Flow through the die;

(4)

Extrusion from the die and further downstream processing.

Noticeably, HME can improve the bioavailability of the poorly water-soluble
active pharmaceutical ingredients by dissolving them into water-soluble polymers. At the
same time, oral dosages with controlled release characteristics can be produced by
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dispersing water-soluble APIs into water-insoluble polymers. The elementary steps of this
process are identical to the ones involved in conventional plastics melt compounding by
extrusion: (1) Feeding particulates; (2) melting; (3) dispersive and distributive mixing;
(4) devolatilization and stripping; (5) pressurization and pumping. However, for
pharmaceutical hot-melt extrusion, the API dissolution is an additional and very important
elementary step, along with melting of the polymeric excipient that precedes it, and mixing
which accelerates the dissolution process. In the case of solid solutions, the drug’s (API)
dissolution is an additional and very important elementary step, along with melting of the
polymeric excipient that precedes it, and mixing which accelerates the dissolution process.
HME provides several advantages over traditional available pharmaceutical
processing techniques such as (1) Increased solubility and bioavailability of waterinsoluble compounds; (2) solvent free process; (3) economical process with reduced
production time, fewer processing steps, and a continuous operation; (4) capabilities of
sustained, modified, and targeted release; (5) better content uniformity in products; (6) no
needs for the compressibility of active ingredients; (7) uniform dispersion of fine particles;
(8) good stability at changing pH and moisture levels and safe application in humans;
(9) reduced number of unit operations and production of a wide range of performance
dosage forms; (10) a range of screw geometries (McGnity et al. 2004),( Jones et al. 2008),
(Grunhagen et al. 1995), (Singhal et al. 2011). However, the HME also have disadvantages
as well. The main drawbacks of HME include thermal process (drug/polymer stability),
use of high viscosity polymers, and excipients required and not suitable for relatively high
temperature sensitive molecules such as microbial species and proteins (Grunhagen et al.
1995), (Singhal et al. 2011), and the newer class of drugs called “biologics”.
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As mentioned previously, the thermal degradation of drugs (API) is one of the
major concern in pharmaceutical HME process. Producing an extrudate that contains a
molecularly dissolved API and at the same time not overexposing the API to high
processing temperature for inappropriately long time is one of the major objectives during
the extrusion of solid solutions. To achieve the balance between complete dissolution of
API and minimal thermal degradation of the API, the dissolution kinetics of the API
particulates inside the molten polymeric matrix during extrusion must be known. Melting
of the polymeric excipient, dispersive/distributive mixing, and API dissolution can occur
simultaneously during extrusion. Therefore, to determine the dissolution kinetics of API,
the above phenomena must be isolated from each other. One way to achieving this is by
exploiting the effect of polymer melting, dispersion and distribution of API particulates
and API dissolution on the melt viscosity of the polymer matrix: melt viscosity decreases
with increasing temperature. Addition of particulates in molten polymers may increase the
melt viscosity. Dissolution of an API into molten polymers as a rule decreases viscosity by
virtue of the plasticizing action of the small particles.
In this work, we determine the impact of shear rate and API species on
dissolution kinetics of API into Eudragit®E PO by performing batch melt-mixing
experiments using a specific following protocol: first we melt-mix the polymer and allow
it to reach steady state, then add the crystalline API quickly and in small quantities. In this
way, we minimize the effect of dispersion and distribution that occurs prior to and during
the dissolution of the API. Following the addition of the API to the molten polymer, the
dissolution kinetics are then determined from the drop in the torque of the processed
formulation by virtue of the API plasticization of the polymer.
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1.3 Distributive Mixing and Dispersive Mixing
The mixing processes in single or twin screw extruders is induced by laminar flow and is
generally categorized into two types: dispersive mixing and distributive mixing. Dispersive
mixing refers to the process involving the laminar flow stress-induced particle size
reduction (i.e. de-agglomeration) of particulate cohesive components such as fillers,
polymer gels, or liquid droplets. Distributive mixing refers to increasing and stretching the
interfacial area between the components lacking a cohesive force in between and
distributing them uniformly throughout the volume of the molten polymer. Dispersive
mixing is mainly controlled by the laminar shear or extensional forces and distributive
mixing is mainly controlled only by the flow-generated strains and does not require high
stresses. According to the definitions, the mixing of miscible liquids is regarded as
distributive mixing, and mixing of hard solid agglomerates, immiscible liquids, and soft
agglomerates is regarded as dispersive mixing (Tadmor, Gogos, 2006). The dispersive and
distributive mixing of solid agglomerates is schematically shown in Figure 1.1.

Figure 1.1 Dispersive mixing and distributive mixing of solid agglomerates and
immiscible liquid droplets (Tasmor and Gogos, 2006).
Source: Z. Tadmor, C. G. Gogos (2006). Principles of Polymer Processing, John Wily & Sons, Inc. Hoboken,
NJ, USA.
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1.4 Dissolution of API Particles in Polymeric Melt
The dissolution of API within the polymer largely depends on their physicochemical
properties. Good blended dispersions require miscibility between the drug and polymer
(Marsac, 2009). In practice, the majority of drug/polymer systems cannot show fully
miscibility, they may likely to show only partial miscibility. This means that there exists a
certain thermodynamic solubility of drugs in polymer matrixes. HME can be carried out in
two distinctly different conditions, referred to here as Case I and Case II:
Case I: The processing temperature is above the melting temperature for a semicrystalline polymer, or the softening temperature for an amorphous polymer, (Tg + 50 ~
100 ºC) but below the melting point of a drug.
Case II: The processing temperature is above both the melting temperature and
the softening temperature of semi-crystalline or amorphous polymers, respectively, and
above the melting point of a drug. It is important to be noted that processing temperature
should be the melt temperature instead of the set temperature of the processing equipment.
It should also be noted that the glass transition temperature of an amorphous polymer or
the melting temperature of a semi-crystalline polymer may decreased if incorporation of
the API (Crowley et al. 2007).
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Figure 1.2 Schematic representation of the morphological changes of the drug and polymer
system in the solution formation process for Case I.
Source: C.G. Gogos, H. Liu, P. Wang, in: Douroumis, “Hot-Melt Extrusion: Pharmaceutical Applications,”
Wiley: Chichester, UK, 2012.

Case I provides a viable method to circumvent the thermal degradation issues. In
Case I, the drug is processed below its melting point and mixed with a polymer melt, then
the solid drug particles gradually dissolve into the polymer excipient melt. And this process
should be able to provide a desirable polymer-drug solid dispersion or solid solution.
During the HME process, the solid API act as a solute and the polymeric melt act as a
solvent. In addition, the dissolution rate and solubility of the API in the polymer will
increase with higher temperature.
The dissolution process of the drug in the polymer melt is schematically shown
in Figure 1.2. Firstly, the drug particles (black) and polymer particles (white) are fed into
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the batch mixer or an extruder. Secondly, the polymer particles start melting due to the
conductive heat from the mixer or extruder barrel and frictional and plastic energy
dissipation. These two phenomena result in a process charge state that the solid drug
particles are suspended in a continuous polymer melt matrix. Thirdly the polymer
molecules start to heat up the API particles and create a mass transfer boundary layer. This
layer shall be continuously wiped away and replaced with fresh polymer melt nearby. The
drug molecules diffuse into the polymer melt through the boundary layer, and the size of
the suspended drug particles will continue to decrease as the diffusion goes. Finally, a
homogeneous solution will be formed.

Figure 1.3 Schematic representation of the morphological changes of the drug and polymer
system in the solution formation process for Case II.
Source: C.G. Gogos, H. Liu, P. Wang, in: Douroumis, “Hot-Melt Extrusion: Pharmaceutical Applications,”
Wiley: Chichester, UK, 2012.
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Case II, on the other hand, involves miscible or partially miscible liquid-liquid
mixing because both the polymer and drug will be melted. As shown in Figure 1.3, the
drug (black) and polymer (white) particles are fed into an extruder and processed by the
screw elements. Due to the heat transfer from the extruder barrel or a batch mixer, and
frictional and plastic dissipation, the polymer particles will melt first. During or after the
melting of the polymer, the drug particles will melt to droplets and be deformed by the
mixing flows generated by the screws. The droplets will be deformed along the shear
direction and blurred the contacting surface between the drug and polymer. As this process
goes on and with diffusion continuously being carried on, we will finally get a
homogeneous drug – polymer solution.
In both cases discussed previously between either the dissolving API particles or
the drug droplets and the molten polymer, the diffusion will happened.

The

“characteristic diffusion time” t D is proportional to the square of the API phase droplet or
ligament radius L or the thin dimension. DAB is the diffusivity of the API into the polymer
melt excipient. They are related by the following useful expression, Equation 1.1.
𝐭𝐃 =

𝐋𝟐
𝐃𝐀𝐁

(1.1)

During the HME process, the relationship between the rate of dissolution of drug particles
in molten polymer excipients, dm/dt, and the solubility, CS, is described by the NoyesWhitney expression, Equation 1.2, as follows:
𝐝𝐦
𝐝𝐭

=

𝐃×𝐀×(𝐂𝐬 −𝐂)

(1.2)

𝐡×𝐕

where m = mass (mol), t = time (s), C = concentration of solute dissolved at a particular
time (mol∙cm–3), CS = equilibrium solubility (mol∙cm–3), D = diffusivity (cm2∙s–1), h =
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apparent thickness (cm) of the aqueous boundary layer (depends on rate of stirring and the
temperature), and A = surface area available for dissolution (cm2).
The equation indicates that the drug particle size and size distribution are
important variables to affect the dissolution rate, because the total contacting surface area
of the drug particles will be changed correspondingly. A higher dissolution rate is expected
with smaller particles. Furthermore, the narrower the drug particle size distribution, the
more uniform the total dissolution time distribution needed for complete dissolution of
drugs in polymer melt will be (Liu, Gogos, 2012). Also, the diffusivity, which determined
by temperature and the property of the particle, plays a significant role in dissolution
process. At some constant temperature, for particles with similar sizes or at same size scale,
the particles with higher diffusivity are expected to have shorter diffusion time. This may
lead to a method to evaluate the diffusive property of the particles (Fang, 2014).
Process parameters have an important impact on the dissolution rate of drug
particulates in polymeric melts. For co-twin screw extruders, the most important process
parameters are the barrel set temperature, the screw speed and the feeding rate. Screw speed
can be used to calculate the “characteristic average” channel shear rate and shear stress:

𝛄=

𝛑×𝐃×𝐧
𝐡×𝟔𝟎

𝛕=𝛄×𝛈

(1.3)
(1.4)

where 𝛾 is shear rate in sec-1; D is the screw diameter in mm; n is the screw speed in rpm;
h is the over-flight clearance in mm; 𝜏 is shear stress in kPa; 𝜂 is the melt viscosity in
Pa*s (Gogos, Liu, Wang, 2012). According to Equation (1.3), for a given extruder, once
the screw speed is fixed, the characteristic shear rate is a constant value.
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In order to raise the dissolution rate, the surface area available have to be consider.
In extrusion process, the dispersive mixing may break up the drug agglomerates or
individual particles due to the high shear forces generated by the high shear screw elements
such as wide kneading blocks or Maddock elements (Tadmor, Gogos, 2006). Then, the
total contacting surface area of the drug particles to the polymeric melt will be larger, thus
the dissolution rate will increase. And the distributive mixing can homogenize the drug
concentration dissolved in the polymeric melt, and leading more polymer melt into contact
with the suspended drug particles. In this way, both effects can raise or maintain the
dissolution rate. Thus, it is expected that with higher shear rate, the dissolution rate would
rise, which could be accomplished through increasing the screw speed of an extruder.
If the mixer set temperature increases, on the one hand, the diffusion coefficient
will increase due to the increased temperature and resultant decreased matrix viscosity; on
the other hand, Cs also will increase. Both of these factors will contribute to an increase of
the API dissolution rate in the molten polymer excipient. As the screw speed increases, the
distributive mixing is improved within the chamber as well, and thus a higher concentration
gradient around the drug particulates is available. Moreover, the thickness of the mass
transfer boundary layer decreases as the screw speed increases. Both effects contribute to
an increased dissolution rate.

1.5 Viscosity of the Melt
The temperature dependent viscosity of a polymer in its molten state affects the melt
extrusion process: the level of temperatures reached because of viscous energy dissipation,
the melting rate, the die flow uniformity and extrudate quality. Polymers with high
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viscosities generate higher melt temperatures and higher melting rates in the screw. They
also require die discharge pressure and more power. For different polymer-drug
formulations, the viscosity of the mixture also varies. The viscosity of the polymers are
determined by a rheometric mechanical spectrometer (Nollenberger and Albers, 2012).
According to Equation (1.3), given the screw speed and the dimension of the barrel and the
rotors, the characteristic channel shear rate could be calculated, but the shear stress and the
viscosity cannot be directly determined independently by the batch mixer: only the overall
torque could be recorded continuously during the evolution of the batch process of polymer
melting, dispersive and distributive mixing of the API as well as the API dissolution
process. In this work, the viscosity of the material at different shear rate was measured
independently to find a relationship between the apparent torque and the viscosity of the
melt mixture.
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CHAPTER 2
MATERIALS AND METHODS

2.1 Materials
Eudragit® E is a copolymer composed of neutral methyl and butyl methacrylate, and
dimethylaminoethyl methacrylate repeating units. It has a Tg ~45˚C. The molar ratio of
three monomers, methyl methacrylate, butyl methacrylate and dimethylaminoethyl
methacrylate, is 2:1:1. Two grades are available which have the same chemical structure
and molecular weight: one is Eudragit® E PO (EPO) in powder form; the other is
Eudragit® E 100 in granular form. This copolymer is soluble up to pH=5 and above this
pH value is capable of swelling and becoming permeable to water. It is widely used for
masking unpleasant tastes and odors of drugs, protecting drugs against moisture, and as a
drug excipient for pharmaceutical applications. In this work, EPO is selected as the model
polymer excipient.
Acetaminophen (APAP) (Spectrum Chemicals, Gardena, CA) was selected as
one of the model crystalline API. APAP is a water-soluble BCS class I drug with a Tm of
169–170 °C.
Quetiapine is select as another model API in this work. Quetiapine is an atypical
antipsychotic which has a dibenzothiazepine structure. The Tm of quetiapine fumarate is
174~175 ˚C (Gohel and Patel, 2013). Due to its poor solubility over the physiological pH
range and high permeability, quetiapine is classified as a BCS class II drug. Quetiapine is
available as fumarate salt in immediate release and extend release formulations (Grzegorz
Garbacz, et al. 2013). In this work, quetiapine fumarate is used in the experiments and QTP
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represents quetiapine fumarate in the rest of the content.

2.2 Methods
2.2.1 Batch Mixer
A batch mixer is used to experimentally investigate the effects of extrusion process
parameters (torque and melt temperature) of the drug-polymer mixing. The batch mixer is
a heated high-shear laminar-flow mixer, which has been extensively used in the plastics
and rubber industry to simulate the extrusion process, reactive extrusion, or optimize the
formulation. The laboratory scale batch mixer used requires only 30-60 g of the material
and many experiments can be performed in a short period of time, thus making it an
attractive choice for the HME study (Ghebre-Sellassie and Martin, 2007). Furthermore, the
screw speeds can be controlled separately without altering the residence time in a batch
mixer, which is difficult to realize if an extruder is used.
All the runs were performed in a Brabender FE-2000 batch intensive mixer
utilizing counter-rotating screws, as illustrated in Figure 2.1. The batch mixer barrel is
heated electrically and cooled by air. The melt temperature sensor measures the actual
processed material temperature during melting and mixing; the torque meter can record the
resistance of material to the flow created by the counter-rotation of the screws. Generally,
about 70-75 vol. % fill degree of the chamber is recommended for good mixing because
the resulting “folding” of the free surfaces is beneficial to distributive mixing. The free
volume in the mixing chamber is 60 ml.
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(a)

(b)

Figure 2.1 The batch mixer (a) and roller screws (b) (Manufactured by Brabender Corp.)
Source: Liu, H. (May 2010). Hot Melt Mixing/Extrusion and Dissolution of Drug (Indomethacin) in Acrylic
Copolymer Matrices. Otto H. York Department of Chemical, Biological and Pharmaceutical Engineering.
Newark, New Jersey Institute of Technology. Ph.D. Dissertation.
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Figure 2.2 The inside of the assembled Brabender batch mixer (without the front plate).

The Brabender batch mixer (Shown as Figures 2.1 and 2.2) was used for
compounding of the materials. All the experiment runs were performed in a Brabender FE2000 batch intensive mixer utilizing Ʃ-counter-rotating screws, as illustrated in Figure
2.1(b). During mixing, the torque arising from the resistance of material to the frictional
forces while the charges in solid particulate form and later after melting, viscous flow
created by the counter-rotation of the screws is recorded along with the melt temperature.
In this research work, the torque sensor lost its sensitivity, so much so that the
torque at low screw speed could not be measured (for example, 25RPM, Shown as Figure
2.3). In this situation, the load cell was replaced while the new load cell isn’t compatible
with the original measurement program. To measure the torque of the melting mixture, the
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new load cell was connected with a control box to read and record data. Calibration of the
load cell was conducted before the experiment. After the change of instrument, the data
recorded by the new load cell compared with previous one is shown as Figure 2.4.

Torque [N*m]

Torque@25RPM
20.00
18.00
16.00
14.00
12.00
10.00
8.00
6.00
4.00
2.00
0.00
0.00

2.00

4.00

6.00

8.00

10.00

12.00

14.00

16.00

18.00

20.00

4.50

5.00

Time [min]
Figure 2.3 Torque vs time measured by old load cell.

Torque Data Comparison@ 140℃, 25RPM
new load cell

old load cell

Torque [N*m]

4.00
3.50
3.00
2.50
2.00
1.50
1.00
0.50
0.00
0.00

0.50

1.00

1.50

2.00

2.50

3.00

Time [min]
Figure 2.4 Data comparison between two load cells.
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3.50

4.00

As shown in Figure 2.2 and 2.3, the new load cell has better sensitivity of the
torque but with much higher “noise”. The noise may arise from the lack of signal smoothing
electronic program.
To minimize the influence of the temperature, the set temperature is selected
before the mixing experiment. The melt temperature is set at 140 ˚C. In this work, for a
given screw speed, the set temperature was set at 140˚C first, then was lowered to keep the
resulting melt temperature at 140˚C 10min after loading the pure polymer.
All the materials were mixed at different screw speed for 20 min, while the set
temperature of the mixer was shown as Table 2.1. The polymer was processed for 10
minutes before the drug was added.

2.2.2 Light Microscopy
To determine the impact of the different APIs, “VHX-5000” light microscopy is used to
approximately evaluate the particle size of two drugs selected in this work.

2.2.3 Rheometric Mechanical Spectrometer (RMS)
RMS-800 is used to determine the viscosity of the mixture at different shear rates. The
plate diameter is 25mm and the gap is ~1.2mm.

18

CHAPTER 3

RESULTS AND DISCUSSION

3.1 API Particulate Dispersion, Distribution, and Dissolution
in the Molten Polymer Excipient
3.1.1 The Set Temperature
To determine the impact of shear rate on dissolution, the impact of melt temperature shall
be eliminated. For the mixture in the batch mixer during melt processing, due to the viscous
dissipation, the melt temperature is higher than the set temperature. Besides the different
screw speeds result in different shear rate and shaft work, which also have different impacts
on the flowing melt average temperature rise. The Brabender barrel set temperatures for
different screw speeds are found as Table 3.1 shown in Materials and Methods as well as
the actual resulting temperature traces shown in Figure 3.1.
Table 3.1 Set temperature at different screw speed

RPM

Set Temperature /˚C

25
50
75
100

135
132
127
122
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140

130

120

110

0.00

5.00

10.00

Temperature [℃]

150

Temperature@25RPM
Temperature@50RPM
Temperature@75RPM
Temperature@100RPM

100
20.00

15.00

Time [min]
Figure 3.1 Melt temperature at different screw speed.
Shown as Figure 3.1, from the point that the drug was added to the end point, the
melt temperature at different conditions was kept at 140˚C, which makes sure that the
impact of temperature is fixed for all the conditions.

3.1.2 Dispersion and Dissolution
To determine the characteristic constants that describe the dissolution kinetics of an API in
a molten polymeric excipient, the API was melt-mixed in the polymer matrix at different
screw speeds and set temperatures following the addition protocol mentioned in Materials
and Methods.
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Figure 3.2 96%EPO-4%APAP vs. 100%EPO control.

Figure 3.2 compares the torque traces of pure EPO (control) and the sample
containing 96%EPO-4%APAP. From the control sample, it can be seen that EPO has
reached a steady state at ~8 min. And the polymer remains stable for another 12 min,
allowing a processing window of 20 min, in which the material was melted and mixed.
This allows the polymer to reach steady state, then the added API is dissolved, and finally
the binary formulation reached steady state. From the torque tracer of the sample with the
drug, we can see that the formulation also remains stable for ~8 min (after the addition of
the API). In the sample with 4% API, the torque drop upon adding the drug was because
the operator opened the cap of the mixer, so that the surface area of the stress decreased.
The torque fluctuation before the point of the maximum torque after the addition of APAP,
indicates the feeding surge, the wetting of the API particles surface and their dispersion
and distribution in the molten polymer matrix. The final equilibrium torque is associated
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with the apparent viscosity of the dissolved drug/polymer melt mixture in the mixing
chamber.
The dispersion, distribution and dissolution of an API occur at the same time
after the addition of the API in the molten polymer. To minimize the effect of dispersion
and distribution of the API in the polymer matrix, we have kept the addition time and the
amount of API added in the molten polymer was kept to a minimum. The evolution of the
torque trace resulting from the addition of the API in the molten polymer can be used to
approximate the amount of the API dissolved while it is dispersed and distributed in the
molten polymer matrix. Figure 3.3 shows the relationship between the amount of dispersed
API particle and the viscosity/torque increment.

Figure 3.3 Viscosity ratios of suspensions and viscosity ratios of suspended drug particles
in molten polymer matrix.
Source: Bigg, D.M, Rheological Behavior of Highly Filled Polymer Melts, Society of Plastics Engineers,
1983.
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The torque trace could be divided into the following parts: 1-2 is the part
beginning with the addition of the drug and ending at the maximum value of torque
recorded during after the drug is added. 2-3 is from the point where the torque is maximized
until the drug fully dissolves. 3-4 is the steady state torque following the dissolution of the
drug (respective points on Figure 3.2). The following “cartoon representation” of the
evolving state of dispersive mixing and dissolution (Figure 3.4) is also used to help depict
the phenomena occurring above:

Figure 3.4 Cartoon representation of the dissolution of APAP in molten EPO.

3.2 Dissolution of the API at Different Shear Rate
3.2.1 Shear Rate
In this work, the shear rate for different screw speeds can be calculated as equation (1.3),
and the shear rates are 42/s, 84/s, 126/s and 168/s, corresponding to 25RPM, 50RPM,
75RPM, and 100RPM.
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3.2.2 Exponential decay
Fang reported that the dissolution process can be expressed by an exponential decay
function (Fang, 2014). Hence, the torque traces were fitted to exponential decay curves.
The expression is:
𝛕 = 𝑪𝟏 × 𝐞−𝑪𝟐∗𝐭 + 𝛕𝟎
Here τ is torque in N/m; t is time in minute; C1 is pre-exponential-number; e is
the base of the natural system of logarithms; C2 is the constant indicating the decay rate; τ0
is the value of τ at t→∞.
In this work, the API is considered to be completely dissolved when the total
torque drops 99% of C1, then the minimum time to complete the dissolution could be
calculated:
𝐶1 + 𝜏0 − 0.99𝐶1 = 𝐶1 × e−𝐶2 ∗t + τ0
The dissolution time td:

𝒕𝒅 =

𝟒. 𝟔𝟎𝟓
𝑪𝟐

Due to the noise originated by the mixer, which was mentioned in Material and
Method, repeated tests were conducted to filter the noise. After normalizing the time and
taking the average torque at the same time point, the averaged torque traces at different
conditions were obtained, shown as Figure 3.5.
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4%APAP+96%EPO
8.00
7.00

Torque [N*m]

6.00
5.00

25RPM

4.00
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3.00

4.00

5.00

Time [min]
Figure 3.5 Averaged torque traces with normalized time.
While fitting the torque traces into exponential decay curves, the torque peak and
the torque at steady state were set as time zero and torque was normalized. All the torque
traces are processed in this method. The exponential-decay curves are shown as Figure 3.6,
and the constants and R2 of the functions are shown as Table 3.2.

4%APAP+96%EPO
25RPM

50RPM

75RPM

100RPM

Torque [N*m]

2.5
2.0
1.5
1.0
0.5
0.0
-0.5 0

0.2

0.4

0.6

0.8

Time [min]

Figure 3.6 Exponential decay curves after normalization.
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Table 3.2 Exponential Decay Model Parameters for 4%APAP at Different RPM
RPM

td/min

C1

C2

τ0

R2

25

1.64

1.0254

2.8103

2.50143

0.9

50

1

1.4429

4.6083

3.92419

0.91

75

0.81

2.312

5.6841

4.68293

0.94

100

0.49

2.4355

9.4931

5.15348

0.92

The physical meaning of the parameters of the exponential decay function are as
follows: C1 is the scaling factor of the decay function and corresponds to the value of the
y-axis (torque) at t=0. In this case, C1 corresponds to the highest value of torque, which is
proportional, for a given material stem and temperature, to the shear rate of the set RPM,
following the addition, dispersion and distribution of the API in the polymer melt, and the
initiation quantity of the API added (point 2 in Figure 3.4). According to “τ = γ × η”, C1
is proportional to γ × η , which means plotting the value of C1 vs. the shear rate yields a
straight line, the slope depends on the dynamic viscosity, and it denotes the proportionality
between the RPM and the corresponding increase in the torque of the melt. C2 in the
exponential decay function indicates the decay rate of the material’s torque or viscosity
due to the dissolution rate of the API. Higher value of C2 means polymer melt’s higher
swiping effect on the surface of the API particle, which is proportional to the shear rate.
Plotting the value of C2 vs. the set RPM yields another straight line, the slope of which
denotes the proportionality between the RPM and the corresponding increase in the
dissolution rate. τ0 is the torque at t→∞. Similar reason as C1, τ0 is proportional to
γ × η. It is also proportional to shear rate. Plotting the value of τ0 vs. the set RPM yields
another straight line.
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C1 vs Shear Rate
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Figure 3.7 C1 vs Shear Rate.
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C2 vs RPM
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Figure 3.8 C2 vs RPM.
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Figure 3.9 τ0 vs Shear Rate.
At the fixed API concentration and processing temperature, the torque can be
expressed as below:
𝜏 = (0.0204n + 0.5341) × exp ( −(0.0845n + 0.3679) t) + 0.035n + 1.8868

(3.1)

For a given melt temperature, the dissolution kinetics is acquired. Now we
consider that the dissolution is completed when the total torque drops 99%, then we have
the dissolution time:
𝒕𝒅 =

𝟒.𝟔𝟎𝟓
𝟎.𝟎𝟖𝟒𝟓𝐧 + 𝟎.𝟑𝟔𝟕𝟗

(3.2)

Equation 3.1 and 3.2 give the whole picture of the dissolution process and the
guidance to minimize the residence time of an extruder for APAP/EPO system at 140 ˚C.
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3.2.3 Drugs Concentration Effect
Figure 3.10 shows the torque traces corresponding to the dissolution process of the API
into the molten polymer (points 2-4 in Figure 3.4) of formulations containing different
amount of APAP at 50RPM and 100RPM. Also, the dissolution process is described as the
following exponential decay function, which is:
𝛕 = 𝑪𝟏 × 𝐞𝑪𝟐 ∗𝐭 + 𝛕𝟎
And the exponential decay constants and R2 are shown in Table 3.3. The value
of C1 is the pre-exponential factor, indicating the torque value at t=0, which is the max
value of the torque. As it shows in Table 3.3, C1 is proportional to the concentration for
both 50RPM and 100RPM. This is consistent with Fang’s research (Fang 2014).
Table 3.3 Exponential Decay Model Parameters for Different Condition and Formulation
Condition
4%APAP
50RPM
8%APAP
50RPM
4%APAP
100RPM
8%APAP
100RPM

td/min

C1

C2

τ0

R2

1.00

1.4528

4.6083

3.9242

0.92

1.07

2.8507

4.2898

3.089

0.98

0.49

2.4355

9.4931

5.1535

0.91

0.65

4.7563

7.047

4.7563

0.96
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Figure 3.10(a) Torque trace at 50RPM.
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Figure 3.10(b) Torque trace at 100RPM.
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3.2.4 Effect of API Species
Light microscopy was used to determine the particle size of two drugs, and Figure 3.11
shows that the APAP particle is slightly larger than the QTP particle but in same scale.
This may lead to faster dissolution for QTP. On the contrary, the torque trace (Figure 3.12)
shows that the dissolution rate of QTP is lower than that of APAP at the same concentration.
The exponential factors are shown as Table 3.4.

Figure 3.11(a) APAP particles.
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Figure 3.11(b) QTP particles.
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Figure 3.12 Torque trace at 100RPM.
Table 3.4

Exponential Decay Model Parameters for Different API

Condition

td/min

C1

C2

τ0

R2

4%APAP 100RPM
4%QTP 100RPM

0.49
0.65

2.4355
1.8793

9.4931
5.6192

5.1535
5.2039

0.92
0.98
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The particle sizes of QTP and APAP are of the same scale while QTP particle is
slightly smaller than APAP particle. This may lead to higher dissolving rate. However, the
experiment shows that at the same concentration and screw speed, the APAP dissolves
faster than QTP. This indicates the stronger plasticization effect of APAP than QTP.
3.2.5 The Viscosity of the API/Excipient Systems at Different Shear Rate
The characteristic channel shear rates are calculated by Equation (1.3), and they are 42/s,
84/s, 126/s and 168/s, corresponding to 25RPM, 50RPM, 75RPM, and 100RPM.
Figure 3.13 shows the rheology results of three API/Excipient melts systems at
140˚C: 4% APAP + 96% EPO, 8% APAP + 92% EPO and 4% QTP + 96% EPO:

(a)
Figure 3.13 Rheology results at 140˚C of: (a) 4% APAP + 96% EPO.
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(b)

(c)
Figure 3.13 Rheology results at 140˚C of: (b) 8% APAP + 92%, (c) 4% QTP +
96% EPO.
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(d)
Figure 3.13 Rheology results at 140˚C of: (d) Summary of dynamic viscosities of the three
API/EPO systems. Note that the frequency of the oscillatory shear deformation is taken to
be the same as the shear rate in laminar flows, such as that in the Brabender batch mixer.

Examining the rheology results, at 140˚C, all of the samples show that G"
(viscous modulus) is always higher than G" (elastic modulus) at all frequencies, indicating
the predominant viscous nature of all the samples at this temperature. Furthermore, the
samples behave like Newtonian fluids at frequencies lower than 1 rad/s. They have a nonNewtonian nature for all the Brabender shear mixing flows, employed in this work, which
are in the range of 40-170 Rad/s. Additionally, both the concentration and the API species
have an effect on dynamic viscosity. Figure 3.13 (d) indicates that the viscosity drops with
the increasing concentration of APAP. That is because the API acts as a plasticizer and the
plasticization effects increases with the rising of the API concentration. As for the two
different API species, the APAP particles has a stronger plasticization effect than QTP
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particles. This is caused by the stronger molecular interaction force between APAP and
EPO, compared to the interaction between QTP and EPO.
Due to the limited shear rate range, the dynamic viscosity data requires
extrapolation. The raw data was fit to the function as shown in Figure 3.14, and the results
are shown in Table 3.5:

Figure 3.14 Dynamic viscosity data analysis.
Table 3.5 Dynamic Viscosities at Given Shear Rates
RPM

25

50

75

100

Shear Rate

42/s

84/s

126/s

168/s

Viscosity

1309 Ps*s

1034 Ps*s

882 Ps*s

783 Ps*s
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Recall that τ = γ × η, and C1 is proportional to γ × η. Here the proportional
relationship is verified:
Table 3.6 Calculation of "γ𝑖 × η𝑖 "
RPM
25
50
75
100

γ / Rad*s-1
42
84
126
168

η / Pa*s
1309
1034
882
783

η*γ
54978
86856
111132
131544

(ηi*γi)/(η1*γ1)
1
1.58
2.02
2.39

C1
1.03
1.44
2.31
2.44

Ci/C1
1
1.4
2.22
2.37

The value of (ηi*γi)/(η1*γ1), C1 and Ci/C1 are closed, which shows C1 is
proportional to γ × η.
Referring the solubility parameter gives us more information on this: using the
group contribution method (Van Krecelen, 1976; Hansen, 2007; Just et al. 2013),

δ = √δ2d + δ2p + δ2h
where:
δd =

δp =

∑ Fdi
V

√∑ F2pi
V

∑ Ehi

δh = √

V

Here δ is the total solubility parameter; δd is the contribution from dispersion
forces; δp is the contribution from polar forces; δh is the contribution from hydrogen
bonding; Fdi is the molar attraction constant from dispersion component; Fpi is the molar
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attraction constant from polar component; Ehi is the hydrogen bonding energy; V is the
molar volume.
Table 3.7 Solubility Parameter Calculation of EPO
Functional

Fdi

Fpi

Ehi

groups

(J1/2•cm3/2•mol-1)

(J1/2•cm3/2•mol-1)

(J•mol-1)

9 -CH3

336.6

0

0

4 >C<

-214.2

0

0

-N<

30.0

150.0

750.0

4-COO-

204.0

450.0

12500.0

9-CH2-

234.6

0

0

453.64 cm3/mol

Molar Volume
δd=11.31MPa1/2

δp=2.01MPa1/2

δh=10.58MPa1/2

δ=15.62MPa1/2

Total

Table 3.8 Solubility Parameter Calculation of APAP
Functional

Fdi

Fpi

Ehi

groups

(J1/2•cm3/2•mol-1)

(J1/2•cm3/2•mol-1)

(J•mol-1)

Phenylene

1173.0

63.7

40.4

-OH Phenyloge

51.0

1300.0

12000.0

-CO-NH-

225.0

400.0

4000.0

-CH3

336.6

0

0

119.97 cm3/mol

Molar Volume
δd=14.88MPa1/2

δp=11.34MPa1/2
δ=23.28MPa1/2

Total
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δh=13.86MPa1/2

Table 3.9 Solubility Parameter Calculation of QTP
Functional

Fdi

Fpi

Ehi

groups

(J1/2•cm3/2•mol-1)

(J1/2•cm3/2•mol-1)

(J•mol-1)

4 Phenylene

1173.0

63.7

40.4

2 -S-

815.9

196.0

297.5

2 -N=

380.0

100.0

250.0

4 -N<

30.0

150.0

750.0

2=C<

-56.7

20.0

0

4 Ring5-

142.8

0

0

16 -CH2-

234.6

0

0

2 -O-

76.5

1225.0

101.0

2 -OH

76.5

1225.0

6060.0

2 -COOH

561.0

833.0

14645.0

2-CH=

255.0

38.0

0

630.79cm3/mol

Molar Volume
δd=21.16MPa1/2

δp=4.37MPa1/2

δh=8.53MPa1/2

δ=23.24MPa1/2

Total

The solubility parameters of APAP, QTP and EPO are 23.28MPa1/2, 23.24MPa1/2
and 15.62MPa1/2. The solubility parameter difference between API and excipient is an
indicator on the miscibility of the system: a system with less than 7MPa 1/2 difference is
generally considered as miscible whereas a system with more than 10 MPa1/2 difference is
unlikely to be miscible (Chokshi et al. 2005). The solubility parameter difference between
APAP/QTP and EPO is 7.6~7.7MPa1/2, which is in the lower end of the
miscibility/immiscibility limit range. The solubility parameter difference between APAP
and EPO (7.66), compared to that between QTP and EPO (7.62) indicates the
approximately same molecular interaction force in two systems. This is not consistent with
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the data of the batch mixing experiments. Then, the experimentally observed faster
dissolution rate of APAP is indicative that one cannot make a strong correlation between
the solubility parameter difference and dissolution rate, although the solubility parameter
helps to predict the miscibility of a given system.
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CHAPTER 4
SUMMARY, CONCLUSIONS, AND FUTURE WORK

4.1 Summary
In this work, we used a batch mixer, light microscopy and rheometric mechanical
spectroscopy to determine the dissolution kinetics of two model APIs and a polymer during
Hot-melt extrusion, under different shear rates. Acetaminophen (APAP) and Eudragit® E
PO (EPO) were selected as the model API/polymer system. In a limited range of cases,
quetiapine fumarate (QTP) was used as a second model API.
For batch mixing experiments, a series of calibration mixing runs were performed to
determine the processing temperature as a function of the shear rate. This allowed us to run
the actual laminar flow dissolution runs at different barrel set temperatures that resulted in
the same melt temperature at different shear rates. In addition, to minimize the effect of the
dispersion of the API in the polymer, the latter was first melt-mixed, then only a small API
quantity was added to the melt minimizing the chances of API particulate agglomeration.
In this way, the resulting modest but easily measurable torque changes following the
addition of the API, were only associated with the dissolution of the API. Analysis of the
raw torque trace data, yielded the expression of the model API dissolution at 140˚C. The
dissolution rate of APIs in polymer excipients was found to be exponentially decaying with
time after the addition of the API particulates characterized by three different decay
function parameters, C1, C2 and τ0. C1 is the scaling factor of the decay function and
corresponds to the value of the y-axis (torque) at t=0. C2 in the exponential decay function
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indicates the decay rate of the material’s torque or viscosity due to the dissolution rate of
the API. As 99% of torque drop was considered as completion of dissolution, the
dissolution time is determined as:𝒕𝒅 =

𝟒.𝟔𝟎𝟓
𝑪𝟐

. τ0 is the torque at t→∞, which is the torque

after complete dissolution.
Also, the effect of concentration on the dissolution rate was examined. By
conducting the same operation on the APAP/EPO system with different API concentration,
the dissolution rate expression was determined, showing that C1 is proportional to the
concentration at the same shear rate.
In addition, the effect of chemical structure of the API on its dissolutions kinetics
was examined by replacing APAP with QTP. While QTP particle size is smaller than that
of APAP, at the same concentration, temperature and shear rate, the dissolution rate of QTP
is lower than that of APAP, which means the intermolecular interactions of the EPO/APAP
system is stronger than in the EPO/QTP system.
RMS experiments were conducted to find the viscoelastic nature of the
API/polymer systems and the direct relationship between shear rate and viscosity. The
results are consistent with the result of previous batch experiments: the viscosity drops with
the increasing concentration of APAP and the dissolved APAP molecules have a stronger
interaction (plasticization effect) with EPO than QTP molecules.
Equations 3.1, equation 3.2 and the specific values of the parameters for the
APAP/EPO API/polymer excipient system can be used to determine the Hot-melt
Extrusion (HME) minimum residence times, which will guarantee the complete dissolution
of the API while minimizing the degradation concern during HME. This reduces the need
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of costly and time-consuming extruder experiments. This work represents a valuable
methodology of specifying the HME process “operating window” for any API/Polymer
excipient system.
In the future, we expect a universal expression of dissolution rate to be developed.
Ideally, for a given API/Polymer excipient system, the dissolution rate could be expressed
as a function of all conditions: screw speed, set temperature and API concentration.
Moreover, more API/Polymer excipient systems are to be examined to give a guidance to
HME engineers in industrial practice.
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